{
    "SPADE_N_15125": {
        "Sequence Information": {
            "Peptide Name": "Galaxamide",
            "Sequence": "XLLXL",
            "Sequence Length": 5,
            "Biological Activity": [
                "Anticancer",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Mitochondrial membrane",
            "Source": "1. Galaxaura ﬁlamentosa",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [],
            "Literature": [
                {
                    "Title": "d-Amino Acid Position Influences the Anticancer Activity of Galaxamide Analogs: An Apoptotic Mechanism Study.",
                    "Pubmed ID": "28287429",
                    "Reference": "Int J Mol Sci. 2017;18:544",
                    "Author": "Bai D, Yu S, Zhong S, Zhao B, Qiu S, Chen J, Lunagariya J, Liao X, Xu S",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/28287429"
                },
                {
                    "Title": "Synthesis of Marine Cyclopeptide Galaxamide Analogues as Potential Anticancer Agents",
                    "Pubmed ID": "35323457",
                    "Reference": "Mar Drugs. 2022;20:158",
                    "Author": "Li D, Liao X, Zhong S, Zhao B, Xu S",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/35323457"
                }
            ],
            "SPADE ID": "SPADE_N_15125",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_00689",
                    "Similarity": 1.0,
                    "Sequence": "HVCLMSFGSSYRVGVHITHEKVAACPRQNQRLYSCDSLRILYHYSCLTTRDLLYICDCSDFENIICLIRLLLNLDFVEVKLV"
                },
                {
                    "SPADE_ID": "SPADE_N_01104",
                    "Similarity": 1.0,
                    "Sequence": "FTLKKSQLLLFFLGTINFSLCEEERNAEEERRDYPEEKDVEVEKR"
                },
                {
                    "SPADE_ID": "SPADE_N_01126",
                    "Similarity": 1.0,
                    "Sequence": "MFTLKKTLLLLFFLGTINLSLCKEERDADEERRDDPDKRDVEVEKRFLSGILKLAFKIPSVLCAVLKNC"
                }
            ],
            "Hemolytic Activity": "Human umbilical vein endothelial cells HUVEC:IC50=>40 µg/ml",
            "Target Organism": "Human hepatocellular carcinoma HepG2(IC50=9.45±0.25µg/ml),Human breast adenocarcinoma MCF-7(IC50=14.08±0.28µg/ml),Human cervical carcinoma HeLa(IC50=4.94±0.19µg/ml),Human breast adenocarcinoma MDA-MB-435(IC50=11.08±0.22µg/ml),Human breast adenocarcinoma MDA-MB-231(IC50=11.33±2.95µg/ml),Human lung carcinoma A549(IC50=6.99±0.63µg/ml)"
        }
    }
}